Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Tracon Pharmaceuticals, Inc. (TCON)  
$0.26 0.00 (0.00%) as of 4:30 Fri 4/5


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 13,680,000
Market Cap: 3.49(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.1322 - $0.67
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   TRACON Pharmaceuticals is a biopharmaceutical company. Co. has a collaboration and clinical trial agreement for the development of envafolimab, an investigational PD-L1 single-domain antibody for the treatment of soft tissue sarcoma in North America. Other clinical stage oncology product candidates include: YH001, which is a monospecific investigational CTLA-4 antibody, that Co. licensed from Eucure (Beijing) Biopharma Co., Ltd. and Biocytogen Pharmaceuticals (Beijing) Co., Ltd., TRC102, which is a small molecule for the treatment of mesothelioma, lung cancer, glioblastoma and solid tumors, and TJ004309, which is a CD73 antibody for the treatment of solid tumors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 1,418,993
Total Buy Value $0 $0 $0 $1,892,637
Total People Bought 0 0 0 3
Total Buy Transactions 0 0 0 30
Total Shares Sold 0 0 4,764,008 4,765,667
Total Sell Value $0 $0 $1,401,571 $1,403,938
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 1 3
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 241
  Page 4 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Brown Scott B. Chief Financial Officer   •       –      –    2021-03-08 4 B $8.30 $8,296 D/D 1,000 3,128 2.74 -36%     
   Theuer Charles President and CEO   •       •      –    2021-01-27 4 B $8.98 $98,771 D/D 11,000 201,232 2.81 -22%     
   Shahrestani Neil Member of 10% Group   –       –       •   2020-12-30 4 B $9.61 $4,999,997 I/I 520,291 2,716,840 1.5 -45%     
   Wiggins Mark C Chief Business Officer   •       –      –    2020-12-29 4 B $10.56 $10,570 D/D 1,000 13,700 2.74 -43%     
   Theuer Charles President and CEO   •       •      –    2020-12-29 4 B $9.98 $9,980 D/D 1,000 190,232 2.81 -43%     
   Opaleye Management Inc. 10% Owner   –       –       •   2020-12-22 4 B $8.06 $3,999,993 I/I 496,277 2,293,371 1.5 -19%     
   Shahrestani Neil Member of 10% Group   –       –       •   2020-11-11 4 B $7.53 $37,629 I/I 5,000 2,196,549 1.5 10%     
   Shahrestani Neil Member of 10% Group   –       –       •   2020-10-30 4 B $4.64 $98,907 I/I 21,300 2,191,549 1.5 100%     
   Shahrestani Neil Member of 10% Group   –       –       •   2020-10-29 4 B $4.77 $36,734 I/I 7,700 2,170,249 1.5 79%     
   Theuer Charles President and CEO   •       •      –    2020-10-21 4 B $4.38 $8,769 D/D 2,000 189,232 2.81 91%     
   Opaleye Management Inc. 10% Owner   –       –       •   2020-10-21 4 B $4.40 $38,060 I/I 8,656 1,797,094 1.5 91%     
   Opaleye Management Inc. 10% Owner   –       –       •   2020-09-24 4 B $4.44 $95,648 I/I 21,534 1,785,438 1.5 119%     
   Theuer Charles President and CEO   •       •      –    2020-09-23 4 B $4.72 $23,599 D/D 5,000 186,882 2.81 116%     
   Opaleye Management Inc. 10% Owner   –       –       •   2020-09-23 4 B $4.83 $276,448 I/I 57,200 1,764,438 1.5 116%     
   Shahrestani Neil Member of 10% Group   –       –       •   2020-09-11 4 B $3.93 $307,017 I/I 78,201 2,162,549 1.5 159%     
   Wiggins Mark C Chief Business Officer   •       –      –    2020-09-10 4 B $4.14 $28,953 D/D 7,000 12,350 2.74 151%     
   Shahrestani Neil Member of 10% Group   –       –       •   2020-09-09 4 B $3.49 $277,460 I/I 79,415 2,084,348 1.5 184%     
   Opaleye Management Inc. 10% Owner   –       –       •   2020-09-09 4 B $3.47 $164,773 I/I 47,500 1,709,438 1.5 184%     
   Shahrestani Neil Member of 10% Group   –       –       •   2020-09-08 4 B $2.90 $38,408 I/I 13,244 2,004,933 1.5 185%     
   Shahrestani Neil Member of 10% Group   –       –       •   2020-09-04 4 B $2.87 $434,502 I/I 151,611 1,991,689 1.5 241%     
   Opaleye Management Inc. 10% Owner   –       –       •   2020-09-04 4 B $2.88 $26,130 I/I 9,058 1,664,438 1.5 241%     
   Theuer Charles President and CEO   •       •      –    2020-09-04 4 B $2.55 $25,750 D/D 10,000 181,882 2.81 241%     
   Shahrestani Neil 10% Owner   –       –       •   2020-09-03 3 IO $0.00 $0 I/I 0 1,840,078 259%     
   Ikarian Capital, Llc 10% Owner   –       –       •   2020-09-03 3 IO $0.00 $0 I/I 0 1,840,078 259%     
   Opaleye Management Inc. 10% Owner   –       –       •   2020-09-02 4 B $2.35 $282,057 I/I 119,800 1,655,946 1.5 357%     
  241 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us